BSX Q3'26 Earnings: EPS estimate is 0.72 USD

What happened

Boston Scientific is set to announce its Q3'26 results on October 28 before the market opens, at 6:30 AM ET. Analysts estimate revenue of 5.06 billion USD and earnings per share of 0.72 USD.

Confirmed

Global impact / market context

Earnings per share shows profit per sale for each share, so the 0.72 USD estimate is a key benchmark. Missing it could pressure the stock, while beating it may support investor confidence in the company's medical device business.

Analyst inference

Prior quarters showed revenue and earnings per share beating estimates, so expectations are elevated. Investors will compare the 5.06 billion USD revenue estimate and 0.72 USD earnings estimate against actual results to judge whether that pattern continues.

Analyst inference

What to watch

1. Watch whether reported revenue reaches the 5.06 billion USD estimate and earnings per share reach 0.72 USD when results are released. Confirmed
2. Compare reported revenue and earnings per share with the estimates of 5.06 billion USD and 0.72 USD to see whether the figures come in above or below expectations. Proposed
3. A revenue or earnings shortfall could prompt investors to reassess growth expectations, affecting the stock and how they position around medical device peers. Analyst inference

Evidence

• Original source link unavailable